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Using intracardiac recordings of electrical activity and programmed electrical stimulation of the heart, the effect of verapamil has been studied on the conduction times and refractory periods of the anomalous bypass in 8 patients with the Wolff-Parkinson-White syndrome. A minimal effect was found on both antegrade and retrograde conduction times. The refractory period of the anomalous bypass when measured antegradely was shortened in 3 patients, unchanged in i, and lengthened in 4. There was a minimal effect on the refractory period when measured for retrograde conduction. A reciprocal supraventricular tachycardia was initiated in 6 patients and in all 6 this tachycardia was terminated after administration of intravenous verapamil. The significance of thesefindings is discussed with especial reference to the prevention and treatment of dysrhythmias complicating Wolff-Parkinson-White syndrome.
Verapamil has been shown to be an effective antidysrhythmic agent in man (Schamroth, Krilder, and Garrett, I972). Fleckenstein et al. (I967) and Singh and Vaughan-Williams (1972) have shown that it does not act as a beta-blocking agent or by a quinidine-like effect on the cell membrane but rather by interference with calcium conduction at the cellular level. Roy, Spurrell, and Sowton (I973) using His bundle electrograms and programmed stimulation of the heart showed that the main effect of verapamil on the specialized conduction system in man was to prolong atrioventricular (AV) junctional conduction times, both antegradely and retrogradely, and to lengthen the refractory period of the AV node. Similar findings were reported for antegrade conduction by Husaini et al. (I973) . This effect was only partially reversible with atropine. It had very little effect on the remainder of the specialized conduction system. It is probably this effect on the AV node, which is responsible for the termination of supraventricular tachycardias which are due to a reciprocal mechanism within the AV node and which makes verapamil an effective agent in the management of this particular dysrhythmia. This agent has also proved effective in terminating tachycardias associated with the Wolff-Parkinson-White (WPW) syndrome (Schamroth et al., I972) . The tachycardias in this condition are commonly thought to be due to a reciprocal mechanism in which antegrade conduction occurs by way of the AV node His system and retrograde conduction by way of an anomalous bypass (Wellens, I97I) . In this situation verapamil might be expected to terminate the tachycardia by blocking conduction in the AV node (the antegrade part of the reciprocal circuit) and in this way break the reciprocal mechanism. The functional properties of the anomalous bypass in the WPW syndrome have been studied by several workers (Castellanos et al., I973) and the effects of drugs on the anomalous bypass have also been assessed (Roelandt, Schamroth, and The refractory period of the anomalous bypass was obtained for antegrade conduction in the following manner. The heart was driven from the right atrium at a constant frequency. At this time the paced complex showed a delta wave, and examination of the His bundle electrogram indicated the occurrence of a fusion beat, formed by anomalous conduction and conduction by way of the AV node His system. Progressively earlier premature beats were induced in the cardiac cycle until conduction by way of the anomalous bypass failed and exclusive normal conduction by way of the AV node His system was seen on the His bundle electrogram and surface electrocardiographic leads. The premature beat interval at which this event occurred was taken as the refractory period of the anomalous bypass. The refractory period of the anomalous bypass was obtained for retrograde conduction by driving the right ventricle at a constant frequency and delivering right ventricular premature beats at progressively earlier intervals in the cardiac cycle. The retrograde conduction times (V-A') were found to be constant with progressively earlier ventricular premature beats, indicating that bypass conduction was occurring (with progressively earlier ventricular premature beats, V-A' times lengthen when retrograde conduction occurs solely by way of the AV node His system). The premature beat interval at which retrograde conduction to the atria failed, or when V-A' times suddenly increased, was taken as the refractory period of the bypass when measured during retrograde conduction. Stl-St2 represents the interval between the stimulus artefact of the last beat of the basic driven rhythm and the stimulus artefact of the induced premature beat.
St-V, conduction time in milliseconds from the stimulus artefact to the earliest onset of ventricular activation.
H-V -to
St-V= zoo Antegrade and retrograde conduction times and refractory periods of the anomalous bypass were measured before the administration of verapamil in all 8 cases, except Cases 5 and 7 where no tachycardia was initiated and so no V-A' conduction in tachycardia could be obtained. (Antegrade conduction times and antegrade refractory periods only were measured in these 2 patients before and after the administration of verapamil.) The refractory period of the bypass was not measured for retrograde conduction in Cases 2, 3, 4, and 5. Reciprocal tachycardia was initiated by a suitably timed premature beat in Cases I, 2, 3, 4, 6, and 8. Verapamil, 10 mg, was then administered intravenously to these patients and in all 6 the tachycardia was terminated 6o to go seconds later. The retrograde conduction times (V-A') were measured during termination ofthe tachycardia, and then antegrade conduction times and antegrade and retrograde refractory periods were measured after the termination of the tachycardia by intravenous verapamil. In Fig. 2 is a recording obtained from the same patient after the administration of verapamil. The basic driving cycle length and premature beat interval are still the same as for Fig. i . The conduction time in the anomalous bypass has been quite unaffected by verapamil and remains constant at i6o msec. However, conduction in the AV node has been delayed, the His potential now occurring 6o msec after the onset of ventricular activation. Table 2 summarizes the antegrade conduction time (St-V) in the anomalous bypass for basic atrially driven beats and atrial premature beats before and after the administration of verapamil in the 8 patients. It will be seen that the variation in conduction time before and after verapamil is never greater than I0 msec and may be either an increase or a decrease in conduction time. Out of i6 measurements before and i6 measurements after adminis- is an induced atrial premature beat with a coupling time of 395 msec (5 msec earlier than in Fig. i) .
The induced atrial premature beat is conducted solely down the AV node His system as indicated by the normal QRS complex on the surface electrocardiographic leads and the fact that the His deflection precedes the QRS complex by a normal value of 30 msec. This atrial premature beat has, therefore, occurred sufficiently early to find the anomalous bypass refractory and the coupling time of this beat therefore represents the refractory period of the anomalous bypass, i.e. 395 msec. Fig. 4 is a tracing obtained from the same patient after the administration of verapamil. It will be seen that the third beat, the induced atrial premature beat, has now been brought back by 5 msec to 390 msec before the refractory period of the bypass is reached, and normal AV nodal His conduction occurs as indicated by a narrow QRS complex with group.bmj.com on April 19, 2017 -Published by http://heart.bmj.com/ Downloaded from Table 3 summarizes the refractory periods for antegrade conduction and retrograde conduction in all 8 patients both before and after the administration of verapamil. It will be seen that the refractory period for antegrade conduction both before and after verapamil is unchanged in only one patient (Case 5). In 3 patients (Cases I, 4, and 7) the refractory period was reduced by 5, 35, and 20 msec, respectively. In Cases 2, 3, 6, and 8 the refractory period has been lengthened by 20, 5, 5, and 40 msec, respectively. The refractory period of the bypass when measured retrogradely was recorded in only 4 patients. It remained unchanged in 3 (Cases i, 6, and 7) and showed a significant prolongation of 8o msec in Case 8. Fig. 5 is a recording obtained from Case I while in reciprocal supraventricular tachycardia. The tachycardia was supraventricular as indicated by the QRS complex of normal width and configuration preceded by a His deflection with a normal and constant HV time. Retrograde conduction (V-A') in the anomalous bypass is I75 msec and antegrade conduction by way of the AV node His system is II5 msec. Fig. 6 is a recording obtained from the same patient during termination of the tachycardia after the intravenous injection of I0 mg verapamil. The tachycardia is terminated after the third beat with block in the antegrade pathway. It will be seen that antegrade conduction (A'-V) by way of the AV node His system has lengthened from II5 msec to i8o msec. This finding is not unexpected; the main effect of verapamil is to slow AV nodal conduction (Husaini et al., I973; Roy et al., I973) . However, the conduction time in the retrograde pathway (V-A') (the anomalous bypass) has been quite unaffected and remains at I75 msec. Table 4 summarizes the retrograde conduction times (V-A') in the anomalous pathway durintachycardia in the 6 patients in whom a tachycardia was initiated both before verapamil was administered and during the last cycle of the tachycardia before termination after verapamil had been administered. It will be seen that in 3 patients (Cases I, 2, and 6) there was no effect on the conduction time in the anomalous bypass after the administration of verapamil. In 2 patients (Cases 3 and 8) the conduction time was increased by 5 msec in each case and in one patient (Case 4) the conduction time was reduced by 5 msec. In these 6 patients it will be seen that the cycle length of the tachycardia (RR) increased significantly before termination after the administration of verapamil. This change must be entirely due to the effect of verapamil on antegrade conduction in the AV node His system, as only a minimal effect was seen on the retrograde conduction times.
Discussion
Medical management of the patient with the WPW syndrome involves the prevention or treatment of any associated dysrhythmias. Two main types of tachycardia occur. Firstly there is the circusmovement supraventricular tachycardia which involves antegrade conduction in the AV node His system and retrograde conduction in the anomalous bypass (the reverse direction is exceptional). Any therapeutic agent which is able to block one part of the reciprocal circuit may be useful in terminating tachycardias of this sort. Drugs which act predominantly on the AV node, such as digitalis, are valuable agents for their blocking action on the antegrade part of the reciprocal circuit. In this study the termination of the reciprocal supraventricular tachycardias was due almost entirely to the effect of verapamil in delaying conduction within the AV node, there being very little effect on the conduction time within the anomalous bypass. Similarly, betablocking agents are known to slow AV nodal conduction (Berkowitz et al., I969; Smithen, Balcon, and Sowton, I97I) and have been shown to be of value in the treatment of reciprocating tachycardias associated with the WPW syndrome (Gibson and Sowton, I969) . Their effectiveness in this situation is most likely due to their action on the AV node. However, Roelandt et al. (I972) showed that the beta-adrenergic receptor blocking drug DL-tiprenolol slowed conduction in both the AV node and the anomalous bypass in patients with the WPW syndrome. This drug could, therefore, be expected to be of particular value in the management of reciprocal tachycardias associated with the WPW syndrome as it delays conduction in both the antegrade and retrograde pathways of the reciprocal circuit. It is, therefore, of value to know the effect of an antidysrhythmic drug on the anomalous bypass as well (Wellens and Durrer, I973) , and this could increase the risk of ventricular fibrillation should atrial fibrillation occur with subsequent conduction to the ventricles at high frequency: this is more likely to occur if the bypass has an inherently short refractory period. Patients with anomalous bypass tracts may well be more liable to develop atrial fibrillation than patients with normal conduction systems (Schamroth and Krikler, i967) , and as such are more vulnerable to the situation described above.
In However, in the remaining 7 patients no untoward response to the drug would be expected should atrial fibrillation develop, and indeed in 6 patients either an insignificant decrease or even an increase in the refractory period of the bypass was found. When the refractory period of the bypass was measured during retrograde conduction no decrease was found. These findings suggest that verapamil is an effective drug in the treatment of reciprocal tachycardias associated with the WPW syndrome. Its effect on the anomalous bypass is such that it can be accepted as a safe drug to use in this condition in most cases but in i of the 8 patients studied verapamil had an effect on the bypass which could lead to the conversion of a benign to a serious dysrhythmia. 
